Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
about
High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis deltaLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaLamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinomaPleiotropic effects of statins in the diseases of the liverKASL clinical practice guidelines: management of chronic hepatitis BAssociation between hepatitis B and metabolic syndrome: Current state of the artClinical Advances in Fibrosis Progression of Chronic Hepatitis B and CQuantification of liver fibrosis in chronic hepatitis B virus infection.Prediction of fibrosis progression in chronic viral hepatitisDoes antiviral therapy reduce complications of cirrhosis?Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelinesManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsThe importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysisHepatocellular carcinoma: Epidemiology, risk factors and pathogenesisMolecular mechanism and treatment of viral hepatitis-related liver fibrosis.Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experienceA novel estimation of the relative economic value in terms of different chronic hepatitis B treatment optionsA new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BInfection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B.Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Biosensors for hepatitis B virus detectionAssessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agentsCurrent hepatitis B treatment guidelines and future research directions.Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort.Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.Hepatitis B virus infection and alcohol consumptionA novel system for predicting liver histopathology in patients with chronic hepatitis BEarly hepatitis B viral DNA clearance predicts treatment response at week 96Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.Influence of transforming growth factor-beta1 gene polymorphism at codon 10 on the development of cirrhosis in chronic hepatitis B virus carriersAntiviral therapy and resistance with hepatitis B virus infection.Hepatitis B virus-induced oncogenesis.Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyA simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effectiveEarly experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa
P2860
Q21132282-EA05FC39-08A3-491E-907F-064CD2E5468DQ24234212-BA4825DE-DF97-49E4-9759-6AD943641089Q24236020-D170807B-35C3-4E94-BE31-F0145471BBC5Q26741176-78C5846C-03D8-42A6-9654-D2B6856BFFFFQ26752475-8BFBFB2B-8757-40B2-A568-4F0F124D7260Q26772343-FA90166E-BCB7-4C0F-BCD0-2B7B01C0BA66Q26781789-86CEA29B-6FA3-48B4-AA7B-6FED75D31410Q26782440-FFD02227-C3E9-4C80-9530-2DC0B0CF8C79Q26823671-0E4DB3B2-18A6-4272-9317-C803C97DEF6AQ26851410-FA3605F5-6C31-4C47-96B6-CC184096C7A4Q27000080-73FFB8C1-2D06-4010-AD41-F366729E8444Q27008984-97CAB43D-2CAC-416B-AADC-973F0DC1B508Q27016075-9BC34D60-4A80-47E4-944B-6B5B5AAE7971Q27489394-A1735774-0864-4FEA-8B09-A70D480C2440Q27692609-69E7D12B-A00D-4777-AB30-4D1E615F8303Q28468387-7E340F5C-5176-4A6C-9152-E33510ED6F40Q28704122-B885E142-ED7D-4308-99FB-E2FA76A6F003Q28741501-0F865AE3-AC57-4F83-8EC7-61B389D0593AQ30151690-3605ABB5-017B-4979-A8E2-3BB7399B0420Q30220690-2C0286C4-BCFC-4915-90D7-E452421970D7Q30374334-8BAABBFC-46B8-474A-BF01-6FCB8D7FDA44Q30391932-6C696A3A-C070-4395-BF6F-E11B2AC4EF8CQ30430287-8DD04B44-6B9F-4EC6-A108-A370423E8520Q30439873-EF09762D-2E20-4219-B4AF-9D1E5F492E70Q30487002-09A60C62-1B20-4041-B85D-1D3EC012EC1BQ30829485-13F5748E-16FE-4250-AFDD-C6D764498F80Q30860824-4AF00C22-C988-400E-9601-E646C435B076Q33492413-BDA967B3-5DF9-4FFC-8DF6-9C47DC96CF92Q33580037-3953AB4C-E1DF-4E67-9ABC-54EFAFC7ED48Q33599503-70681E9F-AB4C-4801-AF42-AA88C3EB7ED1Q33621252-44F6F9DF-BC58-41B9-AD06-A4067CA6AAC8Q33628420-55970AE2-306F-42B2-9872-89B462FC9A37Q33633648-6EC67C59-B8C3-4189-9B9B-9697BAC90AE2Q33718935-FDAC2BF9-2041-4489-A038-88180ECD0B16Q33749894-B718BAC3-8219-4A72-B8F8-EAD2AD739F47Q33787531-1D3F393E-DC9F-4F26-B2F2-6B90607A4490Q33787553-B14B152D-EE22-4E62-BA58-3CE00B3588ECQ33801743-A8F16811-5D21-4EEE-A1CC-FCA434B02C79Q33804151-36DC2ABD-2475-416A-8F8B-A04B5BC4EB52Q33815159-1B55A24D-8002-4F65-BD0F-DA29C6D41FE5
P2860
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@en
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@nl
type
label
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@en
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@nl
prefLabel
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@en
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@nl
P2093
P1433
P1476
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
@en
P2093
Chin-Lan Jen
Hwai-I Yang
Risk Evaluation of Viral Load ...... V (the REVEAL-HBV) Study Group
San-Lin You
Uchenna H Iloeje
P304
P356
10.1053/J.GASTRO.2005.11.016
P407
P577
2006-03-01T00:00:00Z